Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Pyxis Oncology (PYXS) Change in Receivables (2024)

Historic Change in Receivables for Pyxis Oncology (PYXS) over the last 1 years, with Q1 2024 value amounting to $8.0 million.